NO20051770L - Antidepressivt virkende cykloalkylaminderivater av heterocykle-kondenserte benzodioksaner - Google Patents
Antidepressivt virkende cykloalkylaminderivater av heterocykle-kondenserte benzodioksanerInfo
- Publication number
- NO20051770L NO20051770L NO20051770A NO20051770A NO20051770L NO 20051770 L NO20051770 L NO 20051770L NO 20051770 A NO20051770 A NO 20051770A NO 20051770 A NO20051770 A NO 20051770A NO 20051770 L NO20051770 L NO 20051770L
- Authority
- NO
- Norway
- Prior art keywords
- disorder
- benzodioxanes
- depressant
- heterocycle
- condensed
- Prior art date
Links
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical class C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 title 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 206010068631 Childhood depression Diseases 0.000 abstract 1
- 208000022497 Cocaine-Related disease Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000011688 Generalised anxiety disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000027030 Premenstrual dysphoric disease Diseases 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 206010041250 Social phobia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 201000006145 cocaine dependence Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 208000024732 dysthymic disease Diseases 0.000 abstract 1
- 238000011010 flushing procedure Methods 0.000 abstract 1
- 208000029364 generalized anxiety disease Diseases 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 230000001457 vasomotor Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41007202P | 2002-09-12 | 2002-09-12 | |
| US10/659,174 US6911445B2 (en) | 2002-09-12 | 2003-09-10 | Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| PCT/US2003/028459 WO2004024732A1 (fr) | 2002-09-12 | 2003-09-11 | Derives cycloalkylamine antidepresseurs de benzodioxanes fusionnes au niveau des heterocycles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051770L true NO20051770L (no) | 2005-06-07 |
Family
ID=31997897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051770A NO20051770L (no) | 2002-09-12 | 2005-04-11 | Antidepressivt virkende cykloalkylaminderivater av heterocykle-kondenserte benzodioksaner |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6911445B2 (fr) |
| EP (1) | EP1546151B1 (fr) |
| JP (1) | JP2006503040A (fr) |
| KR (1) | KR20050042187A (fr) |
| CN (1) | CN1309722C (fr) |
| AT (1) | ATE323094T1 (fr) |
| AU (1) | AU2003266029A1 (fr) |
| BR (1) | BR0314430A (fr) |
| CA (1) | CA2498131A1 (fr) |
| DE (1) | DE60304590T2 (fr) |
| DK (1) | DK1546151T3 (fr) |
| EC (1) | ECSP055659A (fr) |
| ES (1) | ES2259776T3 (fr) |
| MX (1) | MXPA05002838A (fr) |
| NO (1) | NO20051770L (fr) |
| NZ (1) | NZ539253A (fr) |
| PT (1) | PT1546151E (fr) |
| RU (1) | RU2005107591A (fr) |
| SI (1) | SI1546151T1 (fr) |
| WO (1) | WO2004024732A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200616967A (en) | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| TW200626142A (en) | 2004-09-21 | 2006-08-01 | Glaxo Group Ltd | Chemical compounds |
| JP2008530229A (ja) | 2005-02-17 | 2008-08-07 | ワイス | シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| WO2008042735A1 (fr) * | 2006-09-29 | 2008-04-10 | Wyeth | Tétrahydroquinoline, indoline, et dérivés associés d'aniline de benzodioxan méthylamines fusionnées à un hétérocycle |
| AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| US20090042874A1 (en) * | 2007-05-30 | 2009-02-12 | Wyeth | Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans |
| US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
| WO2026078446A2 (fr) * | 2024-10-08 | 2026-04-16 | Brandaris Therapeutics B.V. | Agonistes du 5-ht2ar 5,6-bicycliques et leurs utilisations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| US5468767A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives |
| AR004229A1 (es) | 1995-11-06 | 1998-11-04 | Wyeth Corp | Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos |
| GB9627005D0 (en) | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
| GB9704948D0 (en) * | 1997-03-11 | 1997-04-30 | Knoll Ag | Therapeutic agents |
| US6162803A (en) * | 1998-04-08 | 2000-12-19 | American Home Products Corp. | Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression |
| CN1304409A (zh) * | 1998-04-08 | 2001-07-18 | 美国家用产品公司 | 用于治疗抑郁症的吲哚－3－基－环己胺衍生物(5－ht1受体拮抗剂) |
| DE60201829T2 (de) | 2001-03-14 | 2005-10-27 | Wyeth | Azaheterocyclylmethylderivative des 2,3-dihydro-1,4-dioxino(2,3-f)chinolin als antidepressivum |
| CN1503798A (zh) | 2001-04-26 | 2004-06-09 | 抗抑郁的氧杂环稠合的－[1,4]苯并二噁烷的氮杂环基甲基衍生物 |
-
2003
- 2003-09-10 US US10/659,174 patent/US6911445B2/en not_active Expired - Fee Related
- 2003-09-11 DE DE60304590T patent/DE60304590T2/de not_active Expired - Fee Related
- 2003-09-11 WO PCT/US2003/028459 patent/WO2004024732A1/fr not_active Ceased
- 2003-09-11 BR BR0314430-5A patent/BR0314430A/pt not_active IP Right Cessation
- 2003-09-11 CA CA002498131A patent/CA2498131A1/fr not_active Abandoned
- 2003-09-11 AU AU2003266029A patent/AU2003266029A1/en not_active Abandoned
- 2003-09-11 MX MXPA05002838A patent/MXPA05002838A/es active IP Right Grant
- 2003-09-11 SI SI200330260T patent/SI1546151T1/sl unknown
- 2003-09-11 AT AT03795686T patent/ATE323094T1/de not_active IP Right Cessation
- 2003-09-11 DK DK03795686T patent/DK1546151T3/da active
- 2003-09-11 NZ NZ539253A patent/NZ539253A/en unknown
- 2003-09-11 ES ES03795686T patent/ES2259776T3/es not_active Expired - Lifetime
- 2003-09-11 EP EP03795686A patent/EP1546151B1/fr not_active Expired - Lifetime
- 2003-09-11 KR KR1020057004091A patent/KR20050042187A/ko not_active Withdrawn
- 2003-09-11 JP JP2004536479A patent/JP2006503040A/ja active Pending
- 2003-09-11 PT PT03795686T patent/PT1546151E/pt unknown
- 2003-09-11 RU RU2005107591/04A patent/RU2005107591A/ru not_active Application Discontinuation
- 2003-09-11 CN CNB038214695A patent/CN1309722C/zh not_active Expired - Fee Related
-
2005
- 2005-03-10 EC EC2005005659A patent/ECSP055659A/es unknown
- 2005-04-11 NO NO20051770A patent/NO20051770L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003266029A1 (en) | 2004-04-30 |
| ES2259776T3 (es) | 2006-10-16 |
| DE60304590T2 (de) | 2007-05-10 |
| KR20050042187A (ko) | 2005-05-04 |
| BR0314430A (pt) | 2005-09-27 |
| CN1681821A (zh) | 2005-10-12 |
| JP2006503040A (ja) | 2006-01-26 |
| US20040171667A1 (en) | 2004-09-02 |
| HK1073849A1 (en) | 2005-10-21 |
| CN1309722C (zh) | 2007-04-11 |
| ATE323094T1 (de) | 2006-04-15 |
| NZ539253A (en) | 2006-09-29 |
| ECSP055659A (es) | 2005-07-06 |
| RU2005107591A (ru) | 2006-01-20 |
| DK1546151T3 (da) | 2006-07-31 |
| MXPA05002838A (es) | 2005-08-16 |
| PT1546151E (pt) | 2006-07-31 |
| CA2498131A1 (fr) | 2004-03-25 |
| WO2004024732A1 (fr) | 2004-03-25 |
| EP1546151B1 (fr) | 2006-04-12 |
| EP1546151A1 (fr) | 2005-06-29 |
| SI1546151T1 (sl) | 2006-08-31 |
| US6911445B2 (en) | 2005-06-28 |
| DE60304590D1 (de) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0314429A (pt) | Derivados de aza-heterociclil-metil antidepressivo e benzodioxanos fundidos por heterociclo | |
| BR0314277A (pt) | Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo | |
| ATE281459T1 (de) | Azaheterocyclylmethyl derivative des 2,3-dihydro- 1,4-dioxino(2,3-f)quinolins als antidepressiva | |
| DE602004030334D1 (de) | Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen | |
| MY147217A (en) | Antibody molecules having specificity for human il-06 | |
| DE502004011239D1 (de) | Verfahren zur dehydratisierung substituierter 4-dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-katalyse | |
| DE60304590D1 (de) | Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen | |
| DE60315843D1 (de) | Antidepressive indolalkylderivate von heterozyklisch-kondensierten benzodioxanmethylaminen | |
| AR066760A1 (es) | Derivados heteroarilo de benzodioxanos heterociclo-fusionados antidepresivos, composiciones farmaceuticas, procesos de obtencion | |
| NO20055208L (no) | 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer | |
| WO2002088136A3 (fr) | Derives azaheterocyclylmethyliques de 1,4,5-trioxa-phenanthrene antidepresseurs | |
| BR0209343A (pt) | Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los | |
| BRPI0607224A2 (pt) | processo para preparação de ciclohexanona e ciclohexanol | |
| BR0314431A (pt) | Derivados de piperidina antidepressiva dos benzodioxanos fundidos por heterocilo | |
| BR0209342A (pt) | Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los | |
| ATE446299T1 (de) | Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin | |
| DE50310200D1 (de) | Verfahren zur herstellung von aminoalkoxybenzylaminen und aminoalkoxybenzonitrilen als zwischenprodukte | |
| CY1107139T1 (el) | Μεθοδος παρασκευης πυρρολιδινοξιμων | |
| BRPI0909824A2 (pt) | 2-aminoquinolinas | |
| CR7726A (es) | Antidepresivos derivados de indoalquilo de benzodioxan metilaminas de heterociclo fusionado | |
| EA200501577A1 (ru) | Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина | |
| ATE417055T1 (de) | Steroid modifizierte solatriosen | |
| ATE487714T1 (de) | Imino-oxazolidine und ihre verwendung als antikoagulantien |